Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

Posted in: Basal Insulin, Bolus Insulin, Insulin Delivery Aug 06 | 2020Mylan Filed for Glargine Interchangeability; Insulet, Mylan, and BD Q2 '20 Earnings Updates Purchase Blast

novo cover image

Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Other Aug 06 | 2020Novo Discontinues its Dual/Triple Agonists for Obesity; Novo Q2 '20 Earnings Update Purchase Blast

mannkind cover image

Posted in: Bolus Insulin Aug 05 | 2020David Kendall to Leave MannKind; MannKind Q2 '20 Earnings Update Purchase Blast

Posted in: Glucose Monitoring, Insulin Delivery, Other, SGLT2i Aug 05 | 2020Livongo to Merge with Teladoc; AZ Partners for HF Diagnostic; ViaCyte Partners with Gore for Novel Membrane Development; Teva Q2 '20 Earnings Update Purchase Blast

Posted in: Dual/triple agonist, Other, SGLT2i Aug 04 | 2020Merck In-licenses Hanmi's Dual Agonist for NASH; Generic Empagliflozin Tentative Approval Purchase Blast

lilly cover image

Posted in: Basal Insulin, Bolus Insulin Aug 03 | 2020Lilly Initiates New Connected Pen Trial Purchase Blast

merck cover image

Posted in: DPP-IVi, SGLT2i Jul 31 | 2020Merck Q2 '20 Earnings Update Purchase Blast

tandem cover image

Posted in: Insulin Delivery Jul 30 | 2020Tandem Q2 '20 Earnings Update Purchase Blast

Posted in: Autologous, BCMA, CAR-T Jul 30 | 2020BMS and bluebird bio Resubmit Ide-cel to FDA; Dynamic H1 2021 BCMA Launch Environment Expected with Janssen Purchase Blast

Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, GLP-1RA, Glucagon, Insulin Delivery, SGLT2i Jul 30 | 2020EMPEROR-Reduced Positive Topline Results; AZ Discontinues its GLP-1RA Small Molecule; Lexicon to Reorganize; Lilly, AZ, and Lexicon Q2 '20 Earnings Updates Purchase Blast

Posted in: Autologous, CAR-T, CD19 Jul 30 | 2020Thoughts on the EMA Validating BMS's Liso-cel Marketing Authorization Application Purchase Blast

abbott cover image

Posted in: Glucose Monitoring Jul 29 | 2020Libre 2 Launched in the US; Libre 2 App Not Yet Available Purchase Blast

sanofi cover image

Posted in: Basal Insulin, Bolus Insulin, GLP-1RA + Basal Jul 29 | 2020Sanofi Q2 '20 Earnings Update Purchase Blast

Posted in: GLP-1RA, Glucose Monitoring, SGLT2i Jul 28 | 2020Dexcom and Pfizer Q2 '20 Earnings Updates Purchase Blast

astrazeneca cover image

Posted in: SGLT2i Jul 28 | 2020DAPA-CKD Hits on All Endpoints Purchase Blast

Posted in: Glucose Monitoring Jul 27 | 2020Nemaura Set to Acquire Healthimation Purchase Blast

biocon cover image

Posted in: Basal Insulin, Bolus Insulin Jul 24 | 2020Biocon Levels-up Insulin Strategy - Biocon CY Q2 '20 Earnings Update Purchase Blast

Posted in: Glucose Monitoring, Insulin Delivery Jul 23 | 2020Dexcom Partners with Current Health for Remote Patient Monitoring; Nemaura to Integrate with Activity Trackers; Roche Q2 '20 Earnings Update Purchase Blast

Posted in: Glucose Monitoring Jul 23 | 2020New Non-Invasive CGM Player Emerges (Movano); Dexcom G6 Direct-to-Apple Watch Delayed?Purchase Blast

Posted in: Allogeneic, BCMA, CD19 Jul 23 | 2020Thoughts on Fate Therapeutics Updates to their CAR-T Programs in DLBCL and MM; Q1 2020 Call Purchase Blast

« prev 1 … 51 52 53 54 55 … 95 next »

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.

Contact BradyLog In